A2 BIO

Trademark usage description

therapeutics in the nature of cells, proteins and protein complexes for the treatment and prevention of cancer, inflammation, and inflammatory disease Read More

Vienna Information

26 . 4 . 1

SquaresCarrés

26 . 4 . 7

Two quadrilaterals, one inside the otherDeux quadrilatères, l'un dans l'autre

26 . 4 . 17

Quadrilaterals containing one or more numeralsQuadrilatères contenant un ou plusieurs chiffres

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 19

Quadrilaterals with inscriptions projecting beyond one or more of the sides thereofQuadrilatères avec inscriptions débordant un ou plusieurs côtés

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

29 . 1 . 8

BlackNoir

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Classification Information

Class [005]
Therapeutics in the nature of cells, proteins and protein complexes for the treatment and prevention of cancer, inflammation, and inflammatory diseases; biotherapeutics for the treatment and prevention of cancer, inflammation, and inflammatory diseases; medicines; pharmaceuticals; pharmaceutical products for the treatment and prevention of cancer and inflammatory diseases; therapeutic targets, namely, cells, proteins and protein complexes, for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutics and cell therapies in the nature of cells, proteins and protein complexes for the treatment of cancer, inflammation, and inflammatory diseases; engineered cell therapies in the nature of cells, proteins and protein complexes for medical purposes, namely, the treatment and prevention of cancer, inflammation and inflammatory diseases; engineered cell therapy platforms; cell platforms for the treatment and prevention of cancer, inflammation and inflammatory diseases; technology platforms for developing and engineering therapeutic cells, therapeutic proteins, therapeutic antibodies, therapeutics and cellular therapies for the treatment and prevention of cancer, inflammation, and inflammatory diseases; platform for autologous and allogeneic cell manufacturing; therapeutics and cell therapies in the nature of cells, proteins and protein complexes targeting targets lost in tumors for the treatment and prevention of cancer, inflammation and inflammatory diseases; gene therapy products, namely, genetically engineered tissues for transplant purposes.

Classification kind code

Class [040]
Custom manufacturing of therapeutics, biotherapeutics, medicines, and pharmaceuticals; manufacturing of cells, therapeutics and cell therapies for the treatment and prevention of cancer, inflammation and inflammatory diseases; biomanufacturing for others; cell therapy manufacturing for others; autologous and allogeneic cell manufacturing for others; manufacturing services for others in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing and engineering of biological cells, cellular targets, proteins, and antibodies for others.

Classification kind code

Class [042]
Medical research services; pharmaceutical and biopharmaceutical research and development services; provision of information in the fields of therapeutics, biotherapeutics, medicines, pharmaceuticals; provision of, and identification and development of, therapeutic targets for others for the treatment and prevention of cancer, inflammation and inflammatory diseases; development of therapeutics and cell therapies for treatment and prevention of cancer, inflammation, and inflammatory diseases; therapeutics and cell therapies targeting targets lost in tumors for the treatment and prevention of cancer, inflammation and inflammatory diseases; biotechnology research, development, testing and analysis for the treatment of cancer, inflammation, and inflammatory diseases; scientific research and development services; providing information relating to treatment and prevention of cancer, inflammation and inflammatory diseases; research, development, engineering and testing services in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; medical laboratory services, namely, tissue material processing and analysis in the field of autologous and allogeneic biologic preparations for medical use; biotechnology laboratory services; scientific and medical laboratory services; genetic engineering services.

Classification kind code

Mark Details

Serial Number

2214822

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 17^th Jan 2024	Search Recorded
Submitted for opposition 20 on 17^th Jan 2024	Examiner's First Report
Submitted for opposition 223 on 17^th Jan 2024	Total Provisional Refusal
Submitted for opposition 256 on 7^th Aug 2023	Notification of Possible Opposition Sent
Submitted for opposition 48 on 1^st Feb 2023	Agent Changed
Submitted for opposition 31 on 13^th Oct 2022	Formalized
Submitted for opposition 1 on 13^th Oct 2022	Created
Submitted for opposition 257 on 6^th Oct 2022	Designation Notification - Madrid Protocol
Submitted for opposition 228 on 6^th Apr 2022	International Registration
Submitted for opposition 30 on 6^th Apr 2022	Filed